Cargando…
Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma
BACKGROUND: Adenoid cystic carcinoma (ACC) is the second most common malignancy of the salivary glands, accounting for ~ 1% of malignant tumors of the head and neck region and 10% of salivary gland neoplasms. Predicting the long-term outcomes of patients with ACC is still challenging, as reliable pr...
Autores principales: | Park, Susan, Vora, Manali, van Zante, Annemieke, Humtsoe, Joseph, Kim, Hyun-Su, Yom, Sue, Agarwal, Shweta, Ha, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350736/ https://www.ncbi.nlm.nih.gov/pubmed/32650834 http://dx.doi.org/10.1186/s40463-020-00446-1 |
Ejemplares similares
-
Development and Characterization of MYB-NFIB Fusion Expression in Adenoid Cystic Carcinoma
por: Humtsoe, Joseph O., et al.
Publicado: (2022) -
Mortality risk after clinical management of recurrent and metastatic adenoid cystic carcinoma
por: Xu, Melody J., et al.
Publicado: (2018) -
Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck
por: Rodriguez-Russo, Carlos A., et al.
Publicado: (2021) -
MYB promotes the growth and metastasis of salivary adenoid cystic carcinoma
por: Xu, Li-Hua, et al.
Publicado: (2019) -
Fatty Acid Binding Protein 7 Is a Molecular Marker in Adenoid Cystic Carcinoma of the Salivary Glands: Implications for Clinical Significance()()
por: Phuchareon, Janyaporn, et al.
Publicado: (2014)